GlassScriptPhysician profile
Nathan Aston
NPI 1568754364
$1,292.16
in general payments reported to CMS, 2019-2025
16 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $775 · 2022: $91.94 · 2023: $124 · 2024: $164 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $441.01 | 2021-2025 | Triathlon, Simpliciti, Tornier Perform Reversed Glenoid |
| Pacira Therapeutics, INC. | $363.37 | 2021 | |
| Ethicon US, LLC | $113.73 | 2021 | |
| Depuy Synthes Sales INC. | $87.51 | 2024 | Monovisc |
| Sanara Medtech INC. | $68.88 | 2025 | Celleraterx |
| Bioventus LLC | $30.15 | 2023-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Ferring Pharmaceuticals INC. | $30.05 | 2021-2023 | Euflexxa |
| Nevro Corp. | $28.96 | 2022 | |
| Amgen INC. | $22.23 | 2025 | Krystexxa |
| Endo USA, INC. | $18.99 | 2024 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $17.36 | 2023 | Iovera, Zilretta, Exparel |
| Boston Scientific Corporation | $16.91 | 2021 | |
| Merck Sharp & Dohme LLC | $13.75 | 2022 | |
| Innocoll Pharmaceuticals Limited | $13.50 | 2022 | |
| Solventum Corporation | $13.16 | 2024 | Prevena Restor Axioform, Prevena |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Aston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.